Hear Drew Weissman, MD, PhD, on the Giants of Gene Therapy Podcast

Yuliya Klochan, MSJ - March 07, 2023

Drew Weissman, MD, PhD, a 2023 Nobel Prize laureate, shared his personal journey and ups and downs of pioneering mRNA vaccines now used for COVID, HIV, food allergies, and more. ASGCT President Hans-Peter Kiem, MD, PhD, hosted the one-on-one conversation in the fourth episode of ASGCT’s Giants of Gene Therapy.

Drew Weissman, MD, PhD, is the Roberts Family Professor in Vaccine Research, Director of Vaccine Research in the Infectious Diseases Division, and Director of the Institute for RNA Innovation at the University of Pennsylvania. He co-created the nucleoside-modified mRNA technology and other mRNA vaccine-related improvements, patented in 2005.  

Dr. Weissman’s inventions have been used in more than a billion administered doses of the Pfizer and Moderna COVID-19 vaccines. They have the potential to address a range of medical conditions. Dr. Weissman is now working on pan-coronavirus, universal flu, HIV, food allergy, and herpes vaccines, as well as mRNA cancer therapeutics. He’s promoting global vaccine access by working with governments and universities around the world, while combating vaccine hesitancy.  

Dr. Weissman has received numerous awards and honors, including the 2023 Nobel Prize in Physiology or Medicine (co-received with Katalin Karikó, PhD). He has been an ASGCT member and Annual Meeting keynote speaker. 

During his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD, Dr. Weissman shared his personal journey and ups and downs of pioneering mRNA vaccines now used for COVID, HIV, food allergies, and more.

You can subscribe to the ASGCT channel wherever you listen to your podcasts (including AppleSpotify, Overcast, Pocket Casts, and more).

Search “ASGCT” in your podcast app to subscribe to the ASGCT Podcast Network

Music by: Steven O'Brien

"Making Progress"

(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)


Yuliya Klochan, MSJ, is ASGCT's senior communications manager

Related Articles


CMC Strategy with Susan D'Costa, PhD—The Issue

Listen now on the ASGCT Podcast Network! - April 16, 2024

CAR T for Acute Myeloid Leukemia with Dr. Marco Davila—Molecular Therapy Podcast

Listen now! - April 09, 2024

Regulatory Landscapes in CGT with Sabrina Mogle—ASGCT's The Issue

Listen now! - March 26, 2024

Hear Drs. David Schaffer and Adam Schieferecke on the Molecular Therapy Podcast

Listen now! - March 12, 2024